Hepion Pharmaceuticals Files Definitive Proxy Statement
Ticker: CTRVP · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, sec-filing
TL;DR
HEPION proxy statement filed. Shareholders vote soon.
AI Summary
Hepion Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025. The filing concerns the company's annual meeting and related matters. Hepion Pharmaceuticals, previously known as ContraVir Pharmaceuticals, Inc. until August 6, 2013, is headquartered in Edison, NJ.
Why It Matters
This filing provides shareholders with essential information regarding the company's governance and upcoming decisions, allowing them to exercise their voting rights.
Risk Assessment
Risk Level: low — A DEF 14A filing is a routine disclosure document for public companies and does not inherently represent a change in risk.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- ContraVir Pharmaceuticals, Inc. (company) — Former company name
- 20250428 (date) — Filing date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit shareholder votes on important corporate matters, such as the election of directors or executive compensation.
When was this filing made by Hepion Pharmaceuticals, Inc.?
Hepion Pharmaceuticals, Inc. filed this Definitive Proxy Statement on April 28, 2025.
What was Hepion Pharmaceuticals, Inc. formerly known as?
Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc. until August 6, 2013.
Where is Hepion Pharmaceuticals, Inc. located?
Hepion Pharmaceuticals, Inc. is located at 399 Thornall Street, First Floor, Edison, NJ 08837.
What is the SIC code for Hepion Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Hepion Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).